Clinical responses to gefinitib after failure of treatment with cetuximab in advanced non-small-cell lung cancer

被引：10

作者：

Raez, LE ^{[1
]}

Lopes, G

Lilenbaum, R

机构：

[1] Univ Miami, Sch Med, Sylvester Comprehens Canc Ctr, Div Hematol Oncol, Miami, FL 33152 USA

[2] Univ Miami, Sch Med, Thorac Oncol Program, Mt Sinai Canc Ctr,Div Hematol Oncol, Miami, FL 33152 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 18期

关键词：

D O I：

10.1200/JCO.2004.00.5165

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：4244 / 4245

页数：2

共 7 条

[1]

Chinnaiyan P, 2004, J CLIN ONCOL, V22, p202S

[2] Review of epidermal growth factor receptor biology [J].

Herbst, RS .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (02) :21-26

[3] Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): Combining anti-EGFR antibody with tyrosine kinase inhibitor [J].

Huang, SM ;

Armstrong, EA ;

Benavente, S ;

Chinnaiyan, P ;

Harari, PM .

CANCER RESEARCH, 2004, 64 (15) :5355-5362

[4] Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer - A randomized trial [J].

Kris, MG ;

Natale, RB ;

Herbst, RS ;

Lynch, TJ ;

Prager, D ;

Belani, CP ;

Schiller, JH ;

Kelly, K ;

Spiridonidis, H ;

Sandler, A ;

Albain, KS ;

Cella, D ;

Wolf, MK ;

Averbuch, SD ;

Ochs, JJ ;

Kay, AC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (16) :2149-2158

[5]

Lynch TJ, 2004, J CLIN ONCOL, V22, p637S

[6]

Matar Pablo, 2003, Proceedings of the American Association for Cancer Research Annual Meeting, V44, P800

[7]

Moyer JD, 1997, CANCER RES, V57, P4838

← 1 →